Assessing the efficacy of a brief universal family skills programme on child behaviour and family functioning in Gilgit-Baltistan, Pakistan: protocol for a feasibility randomised controlled trial of the Strong Families programme.

Autor:	El-Khani A; Prevention, Treatment and Rehabilitation Section, Drug Prevention and Health Branch, Division of Operations, United Nations Office on Drugs and Crime, Wien, Austria., Asif M; Pakistan Institute of Living and Learning, Karachi, Pakistan muqaddasasif@hotmail.com.; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Shahzad S; Pakistan Institute of Living and Learning, Karachi, Pakistan.; University of Karachi, Karachi, Pakistan., Bux MS; Pakistan Institute of Living and Learning, Karachi, Pakistan., Maalouf W; Treatment and Rehabilitation Section, Drug Prevention and Health Branch, Division of Operations, United Nations Office on Drugs and Crime, Vienna, Austria., Rafiq NUZ; Pakistan Institute of Living and Learning, Lahore, Pakistan., Khoso AB; Pakistan Institute of Living and Learning, Karachi, Pakistan.; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Chaudhry IB; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Ziauddin University, Karachi, Sindh, Pakistan., Van Hout MC; Public Health Institute, Liverpool John Moores University, Liverpool, UK., Zadeh Z; Child and Adolescent Mental Health, Pakistan Institute of Living and Learning, Karachi, Pakistan., Tahir A; Pakistan Institute of Living and Learning, Karachi, Pakistan., Memon R; University College London, London, UK., Chaudhry N; Pakistan Institute of Living and Learning, Karachi, Pakistan., Husain N; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Mersey Care NHS Foundation Trust, Liverpool, UK.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2024 Jul 01; Vol. 14 (6), pp. e081557. Date of Electronic Publication: 2024 Jul 01.
DOI:	10.1136/bmjopen-2023-081557
Abstrakt:	Purpose: The global burden of mental health difficulties among children underscores the importance of early prevention. This study aims to assess the efficacy, feasibility and acceptability of the Strong Families programme in enhancing child behaviour and family functioning in low-resource settings in Gilgit-Baltistan, Pakistan. Methods and Analysis: This is a two-arm, multisite feasibility randomised controlled trial with an embedded process evaluation in three districts of Gilgit-Baltistan, namely Gilgit, Hunza and Skardu. 90 families living in these challenged settings, comprising a female primary caregiver aged 18 or above, and at least one child aged 8-15 years, will participate. Participants will be randomly assigned to either receive the Strong Families programme or to the waitlist group. Strong Families is a 7-hour family skills group intervention programme attended by children and their primary caregivers over 3 weeks. The waitlist group will be offered the intervention after their outcome assessment. Three raters will conduct blind assessments at baseline, 2 and 6 weeks postintervention. The primary outcome measures include the feasibility of Strong Families, as determined by families' recruitment and attendance rates, and programme completeness (mean number of sessions attended, attrition rates). The secondary outcomes include assessment of child behaviour, parenting practices, parental adjustment and child resilience. Purposefully selected participants, including up to five caregivers from each site, researchers and facilitators delivering the intervention, will be interviewed. Descriptive statistics will be used to analyse primary and secondary outcomes. The process evaluation will be conducted in terms of programme context, reach, fidelity, dose delivered and received, implementation, and recruitment. Ethics and Dissemination: This study has been approved by the UNODC Drug Prevention and Health Branch in the Headquarters office of Vienna and the National Bioethics Committee of Pakistan. Findings will be disseminated through publication in reputable journals, newsletters and presentations at conferences. Trial Registration Number: NCT05933850. Competing Interests: Competing interests: IBC, NC and NH have disclosed engagements encompassing presentations and consultancy roles with Eli Lilly, Bristol Myers Squibb, Lundbeck, AstraZeneca and Janssen Pharmaceuticals. These interactions led to reimbursements for them or their respective employing institutions. NH and IBC have held positions as trustees at the PILL in the past. NH has also held roles as a trustee for organisations including Manchester Global Foundation, Lancashire Mind and Abaseen Foundation, UK. Additionally, NH is an NIHR senior investigator and serves as the Director of Research and Innovation at Mersey Care NHS Foundation Trust. Importantly, none of the aforementioned companies maintains any financial stake in this research. (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu